InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Cauwenbergh Geert, 董事. Director active across 1 company, notably Phio Pharmaceuticals Corp.. Aggregated, 2 reports have been recorded. History available since 15 February 2022. The latest transaction was disclosed on 17 February 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Geert Cauwenbergh is a Director at Phio Pharmaceuticals Corp. In this role, he participates in overseeing management and making strategic decisions. His experience in the pharmaceutical sector is valuable to the board. Geert Cauwenbergh is committed to ensuring transparency and integrity within the company.